
LFMD Earnings Date: Nov 9, 2026 (Estimated) — LifeMD, Inc.
NASDAQ · Healthcare · Health Information Services
Updated
When is LFMD's next earnings date?
LifeMD, Inc. (LFMD) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.14 on revenue of $48.8M.
How did LFMD do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), LifeMD, Inc. posted EPS of -$0.16 versus the -$0.15 estimate, a miss of 100.0%. Revenue was $47.3M against a $49.2M estimate. The stock's 1-day post-earnings move was -7.6%.
How much does LFMD stock move after earnings?
LFMD beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 19.2% (up or down) in the day after earnings.
About LifeMD, Inc.
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.15 | -0.16 | -100.00% | $47.3M | ❌ Miss | -7.61% | -10.60% | -17.12% |
| 2026-05-06 | Q1 2026 | -0.13 | -0.20 | -53.85% | $50.2M | ❌ Miss | -14.80% | -13.85% | -7.21% |
| 2026-03-09 | Q4 2025 | 0.02 | -0.04 | -300.00% | $46.9M | ❌ Miss | +25.32% | +41.03% | +11.22% |
| 2025-11-17 | Q3 2025 | 0.01 | -0.07 | -800.00% | $60.2M | ❌ Miss | -13.53% | -16.07% | -31.50% |
| 2025-08-05 | Q2 2025 | 0.10 | -0.06 | -160.00% | $62.2M | ❌ Miss | -44.85% | -42.31% | -46.96% |
| 2025-03-10 | Q4 2024 | -0.05 | 0.21 | +520.00% | $64.3M | ✅ Beat | +30.56% | +33.72% | +12.88% |
| 2024-11-07 | Q3 2024 | -0.12 | 0.09 | +175.00% | $53.4M | ✅ Beat | +14.04% | +16.37% | +15.01% |
| 2024-08-07 | Q2 2024 | -0.12 | 0.06 | +150.00% | $50.7M | ✅ Beat | -2.79% | -3.17% | -10.80% |
Showing last 8 quarters.